Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticancer Mouse Characteristic Human Neutrophils in Advanced Recurrent Tumors
NCT06240767Phase 1Recruiting
- Sponsor
- Wuxi People's Hospital
- Start
- Nov 2023
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of granulocyte infusion in solid tumor, sponsored by Wuxi People's Hospital. Primary endpoint: Clinical efficacy evaluation at 6 months. Started Nov 2023; status: recruiting.
02
Drugs
granulocyte infusion
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06240767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06240767.